45
Views
11
CrossRef citations to date
0
Altmetric
Review

Cardiometabolic risk in psoriasis: differential effects of biologic agents

Pages 1229-1235 | Published online: 05 Dec 2008

References

  • AggarwalSGhilardiNXieMH2003Interleukin-23 promotes a distinct CD4 T cell activation state characterized by the production of interleukin-17J Biol Chem2781910412417590
  • AzfarRSGelfandJM2008Psoriasis and metabolic disease: epidemiology and pathophysiologyCurr Opin Rheumatol204162218525354
  • BlauveltA2008T-helper 17 cells in psoriatic plaques and additional genetic links between IL-23 and psoriasisJ Invest Dermatol1281064718408745
  • BovenschenHJVan Vlijmen-WillemsIMVan De KerkhofPC2006Identification of lesional CD4 + CD25 + Foxp3 + regulatory T cells in psoriasisDermatology213111716902287
  • BranenLHovgaardLNitulescuM2004Inhibition of tumor necrosis factor-alpha reduces atherosclerosis in apolipoprotein E knockout miceArterioscler Thromb Vasc Biol2421374215345516
  • ChanWLPejnovicNLiewTV2003NKT cell subsets in infection and inflammationImmunol Lett851596312527223
  • ChengXYuXDingYJ2008The Th17/Treg imbalance in patients with acute coronary syndromeClin Immunol127899718294918
  • ChoiHKHernanMASeegerJD2002Methotrexate and mortality in patients with rheumatoid arthritis: a prospective studyLancet3591173711955534
  • CohenADSherfMVidavskyL2008Association between psoriasis and the metabolic syndrome. A cross-sectional studyDermatology216152518216477
  • Del RinconIO’LearyDHHaasRW2004Effect of glucocorticoids on the arteries in rheumatoid arthritisArthritis Rheum5038132215593231
  • DennyMFThackerSMehtaH2007Interferon-alpha promotes abnormal vasculogenesis in lupus: a potential pathway for premature atherosclerosisBlood11029071517638846
  • DescampsV2005[Cutaneous side effects of alpha interferon]Presse Med3416687216327708
  • DierkesJWestphalS2005Effect of drugs on homocysteine concentrationsSemin Vasc Med51243916047265
  • DominguezHStorgaardHRask-MadsenC2005Metabolic and vascular effects of tumor necrosis factor-alpha blockade with etanercept in obese patients with type 2 diabetesJ Vasc Res425172516155368
  • DuffyDLSpelmanLSMartinNG1993Psoriasis in Australian twinsJ Am Acad Dermatol29428348349859
  • FischerLMSchliengerRGMatterCM2004Discontinuation of nonsteroidal anti-inflammatory drug therapy and risk of acute myocardial infarctionArch Intern Med1642472615596638
  • FitchEHarperESkorchevaI2007Pathophysiology of psoriasis:recent advances on IL-23 and Th17 cytokinesCurr Rheumatol Rep9461718177599
  • GaalJKalmancheyJSzegediA2005[Interferon induced psoriatic arthritis in a patient with renal cancer]Orv Hetil1462503616398316
  • GaspariAA2006Innate and adaptive immunity and the pathophysiology of psoriasisJ Am Acad Dermatol54S678016488332
  • GelfandJMNeimannALShinDB2006Risk of myocardial infarction in patients with psoriasisJama29617354117032986
  • GelfandJMWeinsteinRPorterSB2005Prevalence and treatment of psoriasis in the United Kingdom: a population-based studyArch Dermatol14115374116365254
  • GerliRSchillaciGGiordanoA2004CD4 + CD28- T lymphocytes contribute to early atherosclerotic damage in rheumatoid arthritis patientsCirculation1092744815159291
  • GisondiPTessariGContiA2007Prevalence of metabolic syndrome in patients with psoriasis: a hospital-based case-control studyBr J Dermatol157687317553036
  • Gonzalez-JuanateyCTestaAGarcia-CasteloA2004Active but transient improvement of endothelial function in rheumatoid arthritis patients undergoing long-term treatment with anti-tumor necrosis factor alpha antibodyArthritis Rheum514475015188332
  • GotsmanIGuptaRLichtmanAH2007The influence of the regulatory T lymphocytes on atherosclerosisArterioscler Thromb Vasc Biol272493517901372
  • GriffithsCEBarkerJN2007Pathogenesis and clinical features of psoriasisLancet3702637117658397
  • GrisarJAletahaDSteinerCW2005Depletion of endothelial progenitor cells in the peripheral blood of patients with rheumatoid arthritisCirculation1112041115642766
  • GrundmannSHoeferIUlusansS2005Anti-tumor necrosis factor-{alpha} therapies attenuate adaptive arteriogenesis in the rabbitAm J Physiol Heart Circ Physiol289H149750515923311
  • GudjonssonJEKarasonARunarsdottirEH2006Distinct clinical differences between HLA-Cw*0602 positive and negative psoriasis patients–an analysis of 1019 HLA-C- and HLA-B-typed patientsJ Invest Dermatol126740516439971
  • HaiderASLowesMASuarez-FarinasM2008Identification of cellular pathways of “type 1,” Th17 T cells, and TNF- and inducible nitric oxide synthase-producing dendritic cells in autoimmune inflammation through pharmacogenomic study of cyclosporine A in psoriasisJ Immunol18019132018209089
  • HenselerTChristophersE1995Disease concomitance in psoriasisJ Am Acad Dermatol3298267751469
  • HueberAJMcInnesIB2007Immune regulation in psoriasis and psoriatic arthritis–recent developmentsImmunol Lett114596517928070
  • HurlimannDForsterANollG2002Anti-tumor necrosis factor-alpha treatment improves endothelial function in patients with rheumatoid arthritisCirculation1062184712390945
  • IraceCMancusoGFiaschiE2004Effect of anti TNFalpha therapy on arterial diameter and wall shear stress and HDL cholesterolAtherosclerosis177113815488873
  • JacobssonLTTuressonCGulfeA2005Treatment with tumor necrosis factor blockers is associated with a lower incidence of first cardiovascular events in patients with rheumatoid arthritisJ Rheumatol321213815996054
  • JariwalaSP2007The role of dendritic cells in the immunopathogenesis of psoriasisArch Dermatol Res2993596617680257
  • KagenMHMcCormickTSCooperKD2006Regulatory T cells in psoriasis. Ernst Schering Res Found Workshop193209
  • KaplanMJ2006Cardiovascular disease in rheumatoid arthritisCurr Opin Rheumatol182899716582694
  • KimballABRobinsonDJrWuY2008Cardiovascular disease and risk factors among psoriasis patients in two US healthcare databases, 2001–2002Dermatology217273718349542
  • KiortsisDNMavridisAKVasakosS2005Effects of infliximab treatment on insulin resistance in patients with rheumatoid arthritis and ankylosing spondylitisAnn Rheum Dis64765615458960
  • KomineMKarakawaMTakekoshiT2007Early inflammatory changes in the “perilesional skin”of psoriatic plaques:is there interaction between dendritic cells and keratinocytes?J Invest Dermatol12719152217446902
  • LesueurFLefevreCHasC2007Confirmation of psoriasis susceptibility loci on chromosome 6p21 and 20p13 in French familiesJ Invest Dermatol1271403917344932
  • LudwigRJHerzogCRostockA2007Psoriasis: a possible risk factor for development of coronary artery calcificationBr J Dermatol156271617223866
  • McCareyDWMcInnesIBMadhokR2004Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trialLancet36320152115207950
  • MalerbaMGisondiPRadaeliA2006Plasma homocysteine and folate levels in patients with chronic plaque psoriasisBr J Dermatol1551165917107384
  • MarkuszeskiLBissingerAJanuszI2007Heart rate and arrhythmia in patients with psoriasis vulgarisArch Med Res3864917174725
  • MarraMCampanatiATestaR2007Effect of etanercept on insulin sensitivity in nine patients with psoriasisInt J Immunopathol Pharmacol20731618179745
  • MastrolonardoM2008Sympathetic nervous system dysfunction: a common pathway linking skin and heart morbidity?J Am Acad Dermatol5835218222338
  • MerkleCJMooreIMPentonBS2000Methotrexate causes apoptosis in postmitotic endothelial cellsBiol Res Nurs251411232512
  • NeimannALShinDBWangX2006Prevalence of cardiovascular risk factors in patients with psoriasisJ Am Acad Dermatol558293517052489
  • NestleFOConradCTun-KyiA2005Plasmacytoid predendritic cells initiate psoriasis through interferon-alpha productionJ Exp Med2021354315998792
  • NeylonLHaightJR1983Neocortical projections of the suprageniculate and posterior thalamic nuclei in the marsupial brush-tailed possum, Trichosurus vulpecula (Phalangeridae), with a comparative commentary on the organization of the posterior thalamus in marsupial and placental mammalsJ Comp Neurol217357756886058
  • NickoloffBJQinJZNestleFO2007Immunopathogenesis of psoriasisClin Rev Allergy Immunol33455618094946
  • OffidaniAMFerrettiGTausM1994Lipoprotein peroxidation in adult psoriatic patientsActa Derm Venereol Suppl (Stockh)18638408073834
  • OremACimsitGDegerO1999The significance of autoantibodies against oxidatively modified low-density lipoprotein (LDL) in patients with psoriasisClin Chim Acta28481810437645
  • PennaGRoncariAAmuchasteguiS2005Expression of the inhibitory receptor ILT3 on dendritic cells is dispensable for induction of CD4 + Foxp3 + regulatory T cells by 1,25-dihydroxyvitamin D3Blood1063490716030186
  • PoikolainenKKarvonenJPukkalaE1999Excess mortality related to alcohol and smoking among hospital-treated patients with psoriasisArch Dermatol1351490310606054
  • PopaCNeteaMGRadstakeT2005Influence of anti-tumour necrosis factor therapy on cardiovascular risk factors in patients with active rheumatoid arthritisAnn Rheum Dis64303515231512
  • ProdanovichSMaFTaylorJR2005Methotrexate reduces incidence of vascular diseases in veterans with psoriasis or rheumatoid arthritisJ Am Acad Dermatol52262715692471
  • RajagopalanSSomersECBrookRD2004Endothelial cell apoptosis in systemic lupus erythematosus: a common pathway for abnormal vascular function and thrombosis propensityBlood10336778314726373
  • RappSRFeldmanSRExumML1999Psoriasis causes as much disability as other major medical diseasesJ Am Acad Dermatol41401710459113
  • Rocha-PereiraPSantos-SilvaARebeloI2004The inflammatory response in mild and in severe psoriasisBr J Dermatol1509172815149504
  • RomanMJSalmonJE2007Cardiovascular manifestations of rheumatologic diseasesCirculation11623465517998471
  • RomanMJShankerBADavisA2003Prevalence and correlates of accelerated atherosclerosis in systemic lupus erythematosusN Engl J Med349239940614681505
  • Schmid-OttGJacobsRJagerB1998Stress-induced endocrine and immunological changes in psoriasis patients and healthy controls. A preliminary studyPsychother Psychosom6737429491439
  • SchonMPBoehnckeWH2005PsoriasisN Engl J Med352189991215872205
  • SeishimaMSeishimaMMoriS1994Serum lipid and apolipoprotein levels in patients with psoriasisBr J Dermatol130738428011499
  • ShapiroJCohenADDavidM2007The association between psoriasis, diabetes mellitus, and atherosclerosis in Israel: a case-control studyJ Am Acad Dermatol566293417157411
  • ShirinskyIVShirinskyVS2007Efficacy of simvastatin in plaque psoriasis:A pilot studyJ Am Acad Dermatol575293117707157
  • SommerDMJenischSSuchanM2006Increased prevalence of the metabolic syndrome in patients with moderate to severe psoriasisArch Dermatol Res298321817021763
  • SterryWStroberBEMenterA2007Obesity in psoriasis: the metabolic, clinical and therapeutic implications. Report of an interdisciplinary conference and reviewBr J Dermatol1576495517627791
  • StroberBTellerCYamauchiP2008Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritisBr J DermatolIn press
  • UyanikBSAriZOnurE2002Serum lipids and apolipoproteins in patients with psoriasisClin Chem Lab Med4065811916273
  • WangHPetersTKessD2006Activated macrophages are essential in a murine model for T cell-mediated chronic psoriasiform skin inflammationJ Clin Invest11621051416886059
  • WilenskyRLHamamdzicD2007The molecular basis of vulnerable plaque: potential therapeutic role for immunomodulationCurr Opin Cardiol225455117921743
  • YurciAGuvenKTorunE2007Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis CEur J Gastroenterol Hepatol19811517700270